{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:36:38Z","timestamp":1773264998734,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00404-015-3973-x","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T07:52:39Z","timestamp":1448956359000},"page":"485-492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Adjuvant therapy of uterine clear cell carcinoma: a review"],"prefix":"10.1007","volume":"293","author":[{"given":"Yiqing","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabbie K.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed A.","family":"Elshaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"issue":"1","key":"3973_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A (2015) Cancer statistics. CA Cancer J Clin 65(1):5\u201329. doi: 10.3322\/caac.21254","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"3973_CR2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0360-3016(00)00724-0","volume":"48","author":"RS Smith","year":"2000","unstructured":"Smith RS, Kapp DS, Chen Q, Teng NN (2000) Treatment of high-risk uterine cancer with whole abdominopelvic radiation therapy. Int J Radiat Oncol Biol Phys 48(3):767\u2013778","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"3973_CR3","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/IGC.0000000000000131","volume":"24","author":"HJ Huang","year":"2014","unstructured":"Huang HJ, Tang YH, Chou HH, Yang LY, Chao A, Huang YT, Lin G, Liu FY, Chang TC, Lai CH (2014) Treatment failure in endometrial carcinoma. Int J Gynecol Cancer 24(5):885\u2013893. doi: 10.1097\/IGC.0000000000000131","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"3973_CR4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/gyno.2000.5737","volume":"77","author":"FD Cirisano Jr","year":"2000","unstructured":"Cirisano FD Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL (2000) The outcome of stage I\u2013II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol 77(1):55\u201365. doi: 10.1006\/gyno.2000.5737","journal-title":"Gynecol Oncol"},{"issue":"5","key":"3973_CR5","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0360-3016(02)04404-8","volume":"55","author":"KT Murphy","year":"2003","unstructured":"Murphy KT, Rotmensch J, Yamada SD, Mundt AJ (2003) Outcome and patterns of failure in pathologic stages I\u2013IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 55(5):1272\u20131276","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3973_CR6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00004347-199501000-00006","volume":"14","author":"ML Carcangiu","year":"1995","unstructured":"Carcangiu ML, Chambers JT (1995) Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival. Int J Gynecol Pathol 14(1):30\u201338","journal-title":"Int J Gynecol Pathol"},{"issue":"8","key":"3973_CR7","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1740::AID-CNCR14>3.0.CO;2-Y","volume":"78","author":"VM Abeler","year":"1996","unstructured":"Abeler VM, Vergote IB, Kjorstad KE, Trope CG (1996) Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer 78(8):1740\u20131747","journal-title":"Cancer"},{"issue":"8","key":"3973_CR8","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/1097-0142(19820415)49:8<1511::AID-CNCR2820490802>3.0.CO;2-6","volume":"49","author":"WM Christopherson","year":"1982","unstructured":"Christopherson WM, Alberhasky RC, Connelly PJ (1982) Carcinoma of the endometrium: I. a clinicopathologic study of clear-cell carcinoma and secretory carcinoma. Cancer 49(8):1511\u20131523","journal-title":"Cancer"},{"issue":"1","key":"3973_CR9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/107327480901600107","volume":"16","author":"A Mendivil","year":"2009","unstructured":"Mendivil A, Schuler KM, Gehrig PA (2009) Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. Cancer Control 16(1):46\u201352","journal-title":"Cancer Control"},{"issue":"1","key":"3973_CR10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.brachy.2008.10.005","volume":"9","author":"AJ Fakiris","year":"2010","unstructured":"Fakiris AJ, Henderson M, Lo SS, Look KY, Cardenes HR (2010) Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: the Indiana University experience. Brachytherapy 9(1):61\u201365. doi: 10.1016\/j.brachy.2008.10.005","journal-title":"Brachytherapy"},{"issue":"3","key":"3973_CR11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ygyno.2014.07.005","volume":"134","author":"KF Hsu","year":"2014","unstructured":"Hsu KF, Chou HH, Huang CY, Fu HC, Chiang AJ, Tsai HW, Chen JR, Cheng WF, Ke YM, Chang CC, Chen TH, Lin SH, Ho CM (2014) Prognostic factors and treatment outcomes for patients with surgically staged uterine clear cell carcinoma focusing on the early stage: a Taiwanese gynecologic oncology group study. Gynecol Oncol 134(3):516\u2013522. doi: 10.1016\/j.ygyno.2014.07.005","journal-title":"Gynecol Oncol"},{"issue":"2","key":"3973_CR12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2009.02.003","volume":"113","author":"AB Olawaiye","year":"2009","unstructured":"Olawaiye AB, Boruta DM 2nd (2009) Management of women with clear cell endometrial cancer: a society of gynecologic oncology (SGO) review. Gynecol Oncol 113(2):277\u2013283. doi: 10.1016\/j.ygyno.2009.02.003","journal-title":"Gynecol Oncol"},{"issue":"9 Suppl 3","key":"3973_CR13","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1097\/IGC.0000000000000297","volume":"24","author":"K Hasegawa","year":"2014","unstructured":"Hasegawa K, Nagao S, Yasuda M, Millan D, Viswanathan AN, Glasspool RM, Devouassoux-Shisheboran M, Covens A, Lorusso D, Kurzeder C, Kim JW, Gladieff L, Bryce J, Friedlander M, Fujiwara K (2014) Gynecologic cancer intergroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix. Int J Gynecol Cancer 24(9 Suppl 3):S90\u2013S95. doi: 10.1097\/IGC.0000000000000297","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"3973_CR14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s11912-013-0346-0","volume":"15","author":"RM Glasspool","year":"2013","unstructured":"Glasspool RM, McNeish IA (2013) Clear cell carcinoma of ovary and uterus. Curr Oncol Rep 15(6):566\u2013572. doi: 10.1007\/s11912-013-0346-0","journal-title":"Curr Oncol Rep"},{"issue":"2","key":"3973_CR15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2007.11.008","volume":"108","author":"M Thomas","year":"2008","unstructured":"Thomas M, Mariani A, Wright JD, Madarek EO, Powell MA, Mutch DG, Podratz KC, Dowdy SC (2008) Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review. Gynecol Oncol 108(2):293\u2013297. doi: 10.1016\/j.ygyno.2007.11.008","journal-title":"Gynecol Oncol"},{"key":"3973_CR16","doi-asserted-by":"crossref","first-page":"628084","DOI":"10.1155\/2011\/628084","volume":"2011","author":"J Varughese","year":"2011","unstructured":"Varughese J, Hui P, Lu L, Yu H, Schwartz PE (2011) Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression. J Oncol 2011:628084. doi: 10.1155\/2011\/628084","journal-title":"J Oncol"},{"issue":"4","key":"3973_CR17","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.1016\/j.ijrobp.2011.01.053","volume":"81","author":"A Kim","year":"2011","unstructured":"Kim A, Schreiber D, Rineer J, Choi K, Rotman M (2011) Impact of adjuvant external-beam radiation therapy in early-stage uterine papillary serous and clear cell carcinoma. Int J Radiat Oncol Biol Phys 81(4):e639\u2013e644. doi: 10.1016\/j.ijrobp.2011.01.053","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3973_CR18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2004.05.009","volume":"94","author":"B DuBeshter","year":"2004","unstructured":"DuBeshter B, Estler K, Altobelli K, McDonald S, Glantz C, Angel C (2004) High-dose rate brachytherapy for Stage I\/II papillary serous or clear cell endometrial cancer. Gynecol Oncol 94(2):383\u2013386. doi: 10.1016\/j.ygyno.2004.05.009","journal-title":"Gynecol Oncol"},{"key":"3973_CR19","doi-asserted-by":"crossref","unstructured":"Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, Thigpen JT, Benda JA, Gynecologic Oncology Group S (2006) Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 24(1):36\u201344. doi: 10.1200\/JCO.2004.00.7617","DOI":"10.1200\/JCO.2004.00.7617"},{"issue":"2","key":"3973_CR20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ygyno.2005.08.037","volume":"100","author":"G Sutton","year":"2006","unstructured":"Sutton G, Axelrod JH, Bundy BN, Roy T, Homesley H, Lee RB, Gehrig PA, Zaino R (2006) Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the gynecologic oncology group. Gynecol Oncol 100(2):349\u2013354. doi: 10.1016\/j.ygyno.2005.08.037","journal-title":"Gynecol Oncol"},{"issue":"2","key":"3973_CR21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3802\/jgo.2015.26.2.134","volume":"26","author":"H Mahdi","year":"2015","unstructured":"Mahdi H, Lockhart D, Moselmi-Kebria M (2015) Prognostic impact of lymphadenectomy in uterine clear cell carcinoma. J Gynecol Oncol 26(2):134\u2013140. doi: 10.3802\/jgo.2015.26.2.134","journal-title":"J Gynecol Oncol"},{"key":"3973_CR22","unstructured":"National Comprehensive Cancer Network. Uterine Neoplasms (Version 2.2015). http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/uterine.pdf . Accessed 20 July 2015"},{"issue":"2","key":"3973_CR23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2014.07.078","volume":"134","author":"DS McMeekin","year":"2014","unstructured":"McMeekin DS, Filiaci VL, Aghajanian C, Cho J, Kim JW, DiSilvestro PA, et al (2014) A randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel\/carboplatin chemotherapy (VCB\/C) in patients with high risk (HR), early stage endometrial cancer (EC): a gynecologic oncology group trial. Gynecol Oncol 134(2):438. doi: 10.1016\/j.ygyno.2014.07.078","journal-title":"Gynecol Oncol"},{"key":"3973_CR24","unstructured":"Leiden University Medical Center (2000) Randomized Phase III Trial Comparing Concurrent Chemoradiation and Adjuvant Chemotherapy with Pelvic Radiation Alone in High Risk and Advanced Stage Endometrial Carcinoma: PORTEC-3. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00411138 . Accessed 1 Aug 2015 (NLM Identifier:NCT00411138)"},{"issue":"10","key":"3973_CR25","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1002\/1097-0142(19930515)71:10<3076::AID-CNCR2820711030>3.0.CO;2-Z","volume":"71","author":"P Mallipeddi","year":"1993","unstructured":"Mallipeddi P, Kapp DS, Teng NN (1993) Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma. Cancer 71(10):3076\u20133081","journal-title":"Cancer"},{"issue":"6","key":"3973_CR26","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/0360-3016(89)90948-6","volume":"16","author":"RA Potish","year":"1989","unstructured":"Potish RA (1989) Abdominal radiotherapy for cancer of the uterine cervix and endometrium. Int J Radiat Oncol Biol Phys 16(6):1453\u20131458","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"3973_CR27","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/1097-0142(19911001)68:7<1516::AID-CNCR2820680709>3.0.CO;2-X","volume":"68","author":"AH Frank","year":"1991","unstructured":"Frank AH, Tseng PC, Haffty BG, Papadopoulos DP, Kacinski BM, Dowling SW, Carcangiu ML, Kohorn EI, Chambers JT, Chambers SK et al (1991) Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma. Cancer 68(7):1516\u20131519","journal-title":"Cancer"},{"issue":"4","key":"3973_CR28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/IGC.0b013e31828b15cb","volume":"23","author":"R Yechieli","year":"2013","unstructured":"Yechieli R, Rasool N, Robbins JR, Cogan CM, Elshaikh MA (2013) Adjuvant radiation therapy for patients with type II endometrial carcinoma: impact on tumor recurrence and survival. Int J Gynecol Cancer 23(4):763\u2013768. doi: 10.1097\/IGC.0b013e31828b15cb","journal-title":"Int J Gynecol Cancer"},{"key":"3973_CR29","doi-asserted-by":"crossref","unstructured":"Nout RA, Smit VT, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Kroese MC, van Bunningen BN, Ansink AC, van Putten WL, Creutzberg CL, Group PS (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375(9717):816\u2013823. doi: 10.1016\/S0140-6736(09)62163-2","DOI":"10.1016\/S0140-6736(09)62163-2"},{"issue":"3","key":"3973_CR30","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ygyno.2004.11.050","volume":"96","author":"AJ Fakiris","year":"2005","unstructured":"Fakiris AJ, Moore DH, Reddy SR, Look KY, Yiannoutsos CT, Randall ME, Cardenes HR, Hoosier Oncology G (2005) Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II hoosier oncology group (HOG 97-01) study. Gynecol Oncol 96(3):818\u2013823. doi: 10.1016\/j.ygyno.2004.11.050","journal-title":"Gynecol Oncol"},{"issue":"2","key":"3973_CR31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijrobp.2013.11.003","volume":"88","author":"MA Elshaikh","year":"2014","unstructured":"Elshaikh MA, Vance S, Suri JS, Mahan M, Munkarah A (2014) Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma. Int J Radiat Oncol Biol Phys 88(2):351\u2013356. doi: 10.1016\/j.ijrobp.2013.11.003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3973_CR32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2012.03.011","volume":"85","author":"BM Barney","year":"2013","unstructured":"Barney BM, Petersen IA, Mariani A, Dowdy SC, Bakkum-Gamez JN, Haddock MG (2013) The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer. Int J Radiat Oncol Biol Phys 85(1):109\u2013115. doi: 10.1016\/j.ijrobp.2012.03.011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"3973_CR33","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","volume":"46","author":"T Hogberg","year":"2010","unstructured":"Hogberg T, Signorelli M, de Oliveira CF, Fossati R, Lissoni AA, Sorbe B, Andersson H, Grenman S, Lundgren C, Rosenberg P, Boman K, Tholander B, Scambia G, Reed N, Cormio G, Tognon G, Clarke J, Sawicki T, Zola P, Kristensen G (2010) Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer\u2014results from two randomised studies. Eur J Cancer 46(13):2422\u20132431. doi: 10.1016\/j.ejca.2010.06.002","journal-title":"Eur J Cancer"},{"issue":"19","key":"3973_CR34","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2004.02.088","volume":"22","author":"JT Thigpen","year":"2004","unstructured":"Thigpen JT, Brady MF, Homesley HD, Malfetano J, DuBeshter B, Burger RA, Liao S (2004) Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 22(19):3902\u20133908. doi: 10.1200\/JCO.2004.02.088","journal-title":"J Clin Oncol"},{"issue":"1","key":"3973_CR35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0090-8258(80)90062-1","volume":"10","author":"G Deppe","year":"1980","unstructured":"Deppe G, Cohen CJ, Bruckner HW (1980) Treatment of advanced endometrial adenocarcinoma with cis-dichlorodiammine platinum (II) after intensive prior therapy. Gynecol Oncol 10(1):51\u201354","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3973_CR36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0090-8258(02)00068-9","volume":"88","author":"S Lincoln","year":"2003","unstructured":"Lincoln S, Blessing JA, Lee RB, Rocereto TF (2003) Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a gynecologic oncology group study. Gynecol Oncol 88(3):277\u2013281","journal-title":"Gynecol Oncol"},{"key":"3973_CR37","doi-asserted-by":"crossref","unstructured":"Gallion HH, Brunetto VL, Cibull M, Lentz SS, Reid G, Soper JT, Burger RA, Andersen W, Gynecologic Oncology Group S (2003) Randomized phase III trial of standard timed doxorubicin plus cisplatin versus circadian timed doxorubicin plus cisplatin in stage III and IV or recurrent endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 21(20):3808\u20133813. doi: 10.1200\/JCO.2003.10.083","DOI":"10.1200\/JCO.2003.10.083"},{"issue":"11","key":"3973_CR38","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.2004.07.184","volume":"22","author":"GF Fleming","year":"2004","unstructured":"Fleming GF, Brunetto VL, Cella D, Look KY, Reid GC, Munkarah AR, Kline R, Burger RA, Goodman A, Burks RT (2004) Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 22(11):2159\u20132166. doi: 10.1200\/JCO.2004.07.184","journal-title":"J Clin Oncol"},{"issue":"3","key":"3973_CR39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ygyno.2012.03.034","volume":"125","author":"D Miller","year":"2012","unstructured":"Miller D, Filiaci V, Fleming G, Mannel R, Cohn D, Matsumoto T, Tewari K, DiSilvestro P, Pearl M, Zaino R (2012) Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: a gynecologic oncology group study. Gynecol Oncol 125(3):771\u2013773. doi: 10.1016\/j.ygyno.2012.03.034","journal-title":"Gynecol Oncol"},{"issue":"8","key":"3973_CR40","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/IGC.0000000000000248","volume":"24","author":"LJ Lee","year":"2014","unstructured":"Lee LJ, Bu P, Feltmate C, Viswanathan AN (2014) Adjuvant chemotherapy with external beamradiation therapy for high-grade, node-positive endometrial cancer. Int J Gynecol Cancer 24(8):1441\u20131448. doi: 10.1097\/IGC.0000000000000248","journal-title":"Int J Gynecol Cancer"},{"key":"3973_CR41","unstructured":"Gynecologic Oncology Group (2000) A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel vs. carboplatin and paclitaxel for optimally debulked, advanced endometrial carcinoma. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00942357 . Accessed 5 Aug 2015 (NLM Identifier: NCT00942357)"},{"key":"3973_CR42","doi-asserted-by":"crossref","unstructured":"Elshaikh MA, Yashar CM, Wolfson AH, Cardenes HR, Erickson B, Jhingran A, Jolly S, Kidd E, Lee LJ, Mayr NA, Moore D, Rao GG, Small W, Jr., Varia MA, Wahl AO, Yuh W, Gaffney DK, Expert Panel on Radiation O-G (2014) ACR appropriateness criteria(R) advanced stage endometrial cancer. Am J Clin Oncol 37(4):391\u2013396. doi: 10.1097\/COC.0000000000000098","DOI":"10.1097\/COC.0000000000000098"},{"issue":"3","key":"3973_CR43","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ygyno.2008.11.014","volume":"112","author":"HD Homesley","year":"2009","unstructured":"Homesley HD, Filiaci V, Gibbons SK, Long HJ, Cella D, Spirtos NM, Morris RT, DeGeest K, Lee R, Montag A (2009) A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: a gynecologic oncology group study. Gynecol Oncol 112(3):543\u2013552. doi: 10.1016\/j.ygyno.2008.11.014","journal-title":"Gynecol Oncol"},{"issue":"2","key":"3973_CR44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2004.02.008","volume":"93","author":"M Bruzzone","year":"2004","unstructured":"Bruzzone M, Miglietta L, Franzone P, Gadducci A, Boccardo F (2004) Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III\u2013IV endometrial cancer patients. Gynecol Oncol 93(2):345\u2013352. doi: 10.1016\/j.ygyno.2004.02.008","journal-title":"Gynecol Oncol"},{"issue":"1","key":"3973_CR45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2006.02.007","volume":"103","author":"K Greven","year":"2006","unstructured":"Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T (2006) Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin\/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 103(1):155\u2013159. doi: 10.1016\/j.ygyno.2006.02.007","journal-title":"Gynecol Oncol"},{"issue":"1","key":"3973_CR46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ygyno.2012.10.010","volume":"128","author":"AA Secord","year":"2013","unstructured":"Secord AA, Geller MA, Broadwater G, Holloway R, Shuler K, Dao NY, Gehrig PA, O\u2019Malley DM, Finkler N, Havrilesky LJ (2013) A multicenter evaluation of adjuvant therapy in women with optimally resected stage IIIC endometrial cancer. Gynecol Oncol 128(1):65\u201370. doi: 10.1016\/j.ygyno.2012.10.010","journal-title":"Gynecol Oncol"},{"key":"3973_CR47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7150\/jca.4140","volume":"3","author":"O Fadare","year":"2012","unstructured":"Fadare O, Renshaw IL, Liang SX (2012) Does the loss of ARID1A (BAF-250a) expression in endometrial clear cell carcinomas have any clinicopathologic significance? A pilot assessment. J Cancer 3:129\u2013136. doi: 10.7150\/jca.4140","journal-title":"J Cancer"},{"issue":"5","key":"3973_CR48","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/modpathol.3800057","volume":"17","author":"HJ An","year":"2004","unstructured":"An HJ, Logani S, Isacson C, Ellenson LH (2004) Molecular characterization of uterine clear cell carcinoma. Mod Pathol 17(5):530\u2013537. doi: 10.1038\/modpathol.3800057","journal-title":"Mod Pathol"},{"issue":"5","key":"3973_CR49","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/his.12581","volume":"66","author":"LN Hoang","year":"2015","unstructured":"Hoang LN, McConechy MK, Meng B, McIntyre JB, Ewanowich C, Gilks CB, Huntsman DG, Kobel M, Lee CH (2015) Targeted mutation analysis of endometrial clear cell carcinoma. Histopathology 66(5):664\u2013674. doi: 10.1111\/his.12581","journal-title":"Histopathology"},{"key":"3973_CR50","author":"PS Binder","year":"2015","unstructured":"Binder PS, Prat J, Mutch DG (2015) Molecular staging of gynecological cancer: what is the future? Best Pract Res Clin Obstet Gynaecol. doi: 10.1016\/j.bpobgyn.2015.01.008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"3973_CR51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PGP.0000000000000162","volume":"34","author":"G Han","year":"2015","unstructured":"Han G, Soslow RA, Wethington S, Levine DA, Bogomolniy F, Clement PB, Kobel M, Gilks B, DeLair D (2015) Endometrial carcinomas with clear cells: a study of a heterogeneous group of tumors including interobserver variability, mutation analysis, and immunohistochemistry with HNF-1beta. Int J Gynecol Pathol 34(4):323\u2013333. doi: 10.1097\/PGP.0000000000000162","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"3973_CR52","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1200\/JCO.1997.15.3.1272","volume":"15","author":"AA Ashour","year":"1997","unstructured":"Ashour AA, Verschraegen CF, Kudelka AP, Kavanagh JJ (1997) Paraneoplastic syndromes of gynecologic neoplasms. J Clin Oncol 15(3):1272\u20131282","journal-title":"J Clin Oncol"},{"issue":"2","key":"3973_CR53","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ygyno.2006.08.026","volume":"104","author":"Y Matsuura","year":"2007","unstructured":"Matsuura Y, Robertson G, Marsden DE, Kim SN, Gebski V, Hacker NF (2007) Thromboembolic complications in patients with clear cell carcinoma of the ovary. Gynecol Oncol 104(2):406\u2013410. doi: 10.1016\/j.ygyno.2006.08.026","journal-title":"Gynecol Oncol"},{"issue":"6","key":"3973_CR54","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10147-005-0517-6","volume":"10","author":"M Toyoda","year":"2005","unstructured":"Toyoda M, Satoh T, Takano K, Sato NO, Oki A, Tsunoda H, Yoshikawa H (2005) Successful diagnosis of thromboembolism before surgery in a woman with clear cell adenocarcinoma of the endometrium. Int J Clin Oncol 10(6):444\u2013446. doi: 10.1007\/s10147-005-0517-6","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"3973_CR55","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ygyno.2012.12.014","volume":"128","author":"K Matsuo","year":"2013","unstructured":"Matsuo K, Yessaian AA, Lin YG, Pham HQ, Muderspach LI, Liebman HA, Morrow CP, Roman LD (2013) Predictive model of venous thromboembolism in endometrial cancer. Gynecol Oncol 128(3):544\u2013551. doi: 10.1016\/j.ygyno.2012.12.014","journal-title":"Gynecol Oncol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-015-3973-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-015-3973-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-015-3973-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T03:20:00Z","timestamp":1567394400000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-015-3973-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,1]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["3973"],"URL":"https:\/\/doi.org\/10.1007\/s00404-015-3973-x","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,1]]}}}